NDC 17856-0672-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-01
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-01
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Proficient Rx LP | 0a14eb9a-0385-40e9-a7ec-71435450ac91 | 2026-08-01 | Warnings, Adverse reactions | NMH84OZK2B |
| Topwin Speedy Enema | GLYCERIN | Health Chemical Pharmaceutical Co., Ltd | 3ba8c3d2-1780-42e1-bec5-8f98771d475e | 2026-07-27 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | St. Mary's Medical Park Pharmacy | 57b0a1e5-5dfa-64a0-e063-6394a90acf36 | 2026-07-24 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | Henry Schein, Inc. | 1a44601b-c31c-4779-a688-28cc4cc75e8b | 2026-07-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | PDC6A3C0OX |
| ondansetron hydrochloride | ONDANSETRON HYDROCHLORIDE | Ipca Laboratories Limited | 7ab3210e-eed1-479a-afc0-f72b5b776883 | 2026-07-22 | Warnings, Adverse reactions | NMH84OZK2B |
| Xenleta | LEFAMULIN ACETATE | Meitheal Pharmaceuticals Inc. | eb972ea8-7502-422e-84bb-66cb8e93ca06 | 2026-07-22 | Warnings, Adverse reactions | XF417D3PSL |
| ondansetron | ONDANSETRON HYDROCHLORIDE | Ascend Laboratories, LLC | 2edc0788-dc38-4d21-ba8e-71f159e2d3b1 | 2026-07-22 | Warnings, Adverse reactions | NMH84OZK2B |
| ondansetron | ONDANSETRON HYDROCHLORIDE | Cardinal Health 107, LLC | cb02f2d7-31a9-4f12-880e-7ce7d85440d4 | 2026-07-17 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | 3f2e8efe-7fd4-407c-a77b-bd6dd04608e2 | 2026-07-10 | Warnings, Adverse reactions | NMH84OZK2B |
| Freskaro Ear Drops for Swimmers | FRESKARO EAR DROPS FOR SWIMMERS | Pharma Nobis, LLC | 4f724d85-cd38-41da-e063-6394a90a9fd7 | 2026-07-08 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | REMEDYREPACK INC. | ee3e8cbe-4f0b-4361-a1b5-8329d85a2932 | 2026-07-08 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Unit Dose Solutions, Inc. | 561dce26-92fa-e00b-e063-6294a90a1ab2 | 2026-07-08 | Warnings, Adverse reactions | NMH84OZK2B |
| Artificial Tears | ARTIFICIAL TEARS | AvPAK | f18bebf2-1936-658f-e053-2a95a90a5012 | 2026-07-07 | Warnings | PDC6A3C0OX |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | PDC6A3C0OX |
| ONDANSETRON | ONDANSETRON | Sportpharm LLC | de72f1ec-75dd-4659-a1a0-32b28b72c799 | 2026-07-02 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | St. Mary's Medical Park Pharmacy | 58f16a00-3e66-29de-e053-2991aa0a59a0 | 2026-06-26 | Warnings, Adverse reactions | NMH84OZK2B |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552d9018-cc7d-7e1a-e063-6294a90a3322 | 2026-06-26 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-06-26 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 1b9c2d9f-62a8-4d26-a041-a598bc59e300 | 2026-06-26 | Warnings, Adverse reactions | NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.